InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
8
T+90 hit rate
37%
T+90 mean return
-3.5%
Across 62 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Campbell Bradley L, Chief Operating Officer. Director active across 2 companies, notably Amicus Therapeutics, INC.. Cumulatively, 80 filings have been recorded. Split: 0 buy · 8 sells. Total volume traded: €670k. History available since 3 May 2021. The latest transaction was disclosed on 26 December 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations80 total
108,602 shares@ US$14.2522.9% of flowCommon StockSEC:0001193125-25-337338:0
13,375 shares@ US$8.901.9% of flowCommon StockSEC:0000950170-25-041503:0
400 shares@ US$9.030.1% of flowCommon StockSEC:0000950170-25-025118:0
137,075 shares0Common StockSEC:0000950170-25-020034:0
20,647 shares@ US$9.313.2% of flowCommon StockSEC:0000950170-25-002425:0
7,500 shares@ US$8.611.1% of flowCommon StockSEC:0000950170-24-132964:0
7,500 shares@ US$10.01661.2% of flowCommon StockSEC:0000950170-24-132964:1
7,901 shares@ US$12.281.5% of flowCommon StockSEC:0000950170-24-123557:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-120981:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-112905:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-104073:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-091099:0
6,100 shares@ US$10.00481.0% of flowCommon StockSEC:0000950170-24-082476:1
6,100 shares@ US$8.610.8% of flowCommon StockSEC:0000950170-24-082476:0
1,400 shares@ US$8.610.2% of flowCommon StockSEC:0000950170-24-081542:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-069357:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-053058:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-041367:0
13,375 shares@ US$11.482.5% of flowCommon StockSEC:0000950170-24-033713:0
28,810 shares0Common StockSEC:0000950170-24-032409:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-026266:0
8,333 shares@ US$12.281.7% of flowCommon StockSEC:0000950170-24-026266:1
15,833 shares@ US$13.13823.4% of flowCommon StockSEC:0000950170-24-026266:2
4,167 shares@ US$14.000.9% of flowCommon StockSEC:0000950170-24-017267:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-011434:0
25 of 80 declarations
About Campbell Bradley L
Campbell Bradley L is the Chief Operating Officer at AMICUS THERAPEUTICS, INC.
